Status:
RECRUITING
GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial
Lead Sponsor:
Goethe University
Conditions:
Acute Lymphoblastic Leukemia
Leukemia
Eligibility:
All Genders
18+ years
Brief Summary
The GMALL registry serves the purpose of ALL research and quality assurance. The Registry collects data about diagnostics, treatment and outcome of Adult ALL Patients in the clinical routine, whether ...
Eligibility Criteria
Inclusion Criteria:
- Acute Lymphoblastic Leukemia (All Subtypes) if treated according to ALL protocols
- Other Types of Leukemia (NK Cell Lymphoma/Leukemia, Biphenotypic Acute Leukemia) if treated according to ALL protocols
- Non-Hodgkin's Lymphoma of Following Subtypes: Burkitt Lymphoma, B Cell Lymphoma, B- or T-lineage Lymphoblastic Lymphoma, Anaplastic Large Cell Lymphoma, Other NHL) if treated according to B-ALL protocols
- Age minimum 18 yrs
Key Trial Info
Start Date :
February 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2035
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT02872987
Start Date
February 1 2009
End Date
December 1 2035
Last Update
December 5 2025
Active Locations (152)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätsklinikum Graz
Graz, Austria
2
LKH-Hochsteiermark Leoben
Leoben, Austria
3
Hanusch-Krankenhaus Wien
Vienna, Austria
4
University Hospital of Frankfurt (Main)
Frankfurt am Main, Hesse, Germany, 60590